home / stock / nuro / nuro news

NURO News and Press, NeuroMetrix Inc. From 06/21/23

Stock Information
Company Name: NeuroMetrix Inc.
Stock Symbol: NURO
Market: NASDAQ
Website: neurometrix.com
Menu
NURO NURO Quote NURO Short NURO News NURO Articles NURO Message Board
Get NURO Alerts

News, Short Squeeze, Breakout and More Instantly...
NURO - NKLA, OPEN and HUT are among pre market gainers

2023-06-21 08:27:37 ET Greenpro Capital  ( GRNQ ) +12% . Chemomab Therapeutics  ( CMMB ) +14% Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023. PureCycle Technologies ( PCT ) +15% s...
NURO - Diabetic Peripheral Neuropathy Screening That Includes DPNCheck® Predicts Mortality In A Prospective Clinical Study

WOBURN, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted presentation of new clinical data at the Diabetes UK meeting held April 23-26 in Liverpool, UK. The scientific poster was titled "Abnormal combined diabetic peripheral neuropathy (DPN)-check and SUDOSCAN resul...

NURO - Quell® Demonstrates Encouraging Clinical Trial Results in Chemotherapy Induced Peripheral Neuropathy (CIPN)

WOBURN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial of Quell titled "Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induce...

NURO - ACGN, HHS and NH among mid-day movers

2023-05-03 13:05:45 ET Gainers: ImmunoGen ( IMGN ) +124% . GD Culture Group Limited ( GDC ) +115% . Aptorum Group Limited ( APM ) +92% . Aceragen ( ACGN ) +77% . NantHealth ( NH ) +57% . Sentage Holdings ( SNTG ) +61% ...
NURO - NeuroMetrix, Inc. (NURO) Q1 2023 Earnings Call Transcript

2023-05-03 12:41:02 ET NeuroMetrix, Inc. (NURO) Q1 2023 Earnings Conference Call May 03, 2023, 08:00 ET Company Participants Thomas Higgins - SVP, CFO & Treasurer Shai Gozani - Founder, Chairman, CEO, President & Secretary Conference Call Participants ...

NURO - Aptorum, ImmunoGen top healthcare gainers; Assure, China Jo-Jo Drugstores among losers

2023-05-03 10:01:41 ET Gainers: Aptorum ( APM ) +133% . ImmunoGen ( IMGN ) +123% . Akanda ( AKAN ) +63% . Mersana Therapeutics ( MRSN ) +37% . CNS Pharmaceuticals ( CNSP ) +25% . Losers: Assure ( IONM ) -38% ....

NURO - NeuroMetrix GAAP EPS of -$0.20, revenue of $1.7M

2023-05-03 07:24:25 ET NeuroMetrix press release ( NASDAQ: NURO ): Q1 GAAP EPS of -$0.20. Revenue of $1.7M (-26.1% Y/Y). Gross profit in Q1 2023 was $1.2 million, a decrease of $0.6 million from the first quarter of 2022. The Q1 2023 gross margin rate contracted t...
NURO - NeuroMetrix Reports Q1 2023 Financial Results

WOBURN, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2023. The Company’s mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on populatio...

NURO - NeuroMetrix, Inc. Announces Date for First Quarter 2023 Financial Results Conference Call

WOBURN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2023 first quarter financial results before the opening of the market on May 3, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on May 3, 2023 to ...

NURO - NeuroMetrix to Exhibit Quell® Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meeting

WOBURN, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39 th Annual Meeting on March 23 - 26 in Ft. Lauderdale, FL. In addition, two scientific posters reporting new data on the use of Quell i...
Previous 10 Next 10